Clinical Dilemmas in Inflammatory Bowel Disease

DESCRIPTION

Evidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease

Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting.

Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments.

This book is suitable for all medical professionals involved in the care of patients with IBD: established and trainee gastroenterologists, colorectal surgeons, pathologists, radiologists, specialist nurses, pharmacists, dieticians and counsellors

TABLE OF CONTENTS

• Part 1 Investigating IBD in the 21st Century
  1 Capsule endoscopy: do we need it?
  2 Pathology reports - pitfalls for the unwary
  3 Non-invasive diagnosis and assessment
  4 What is the best way to image perianal Crohn's disease?
  5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome
  6 Abnormal liver tests - what should we do about them?
• Part 2 Medical Treatment: Making the Most of What We've Got
  5-ASA drugs
  7 Is monitoring necessary?
  8 Do they have a role in Crohn's disease?
  Steroids
  9 Steroids in Crohn's: are they obsolete?
  Antibiotics for Crohn's disease
  10 Antibiotics: which, when and for how long?
  11 Mycobacterium avium paratuberculosis in Crohn's disease: player or spectator?
  Immunomodulators
  12 TPMT testing: is it essential?
  13 6-Mercaptopurine or azathioprine?
  14 Thiopurines: how long should we use them for?
  15 Making the most of methotrexate
  16 Cyclosporine: balancing risk and benefit
  Infliximab
  17 Contraindications - absolute or relative?
  18 How can we prevent tuberculosis?
  19 Dealing with infusion reactions
  20 Use in ulcerative colitis
  21 Infliximab and surgery: health or hazard?
  Nutritional therapy for Crohn's disease
  22 Nutritional therapy for Crohn's disease: is it for adults?
• Part 3 Medical Treatment: What's Round the Corner?
  23 Trials and tribulations - interpreting clinical trials in IBD
  24 Genetics - clinical and therapeutic applications
  25 Probiotics - separating science from snakeoil
  26 Worms
  27 Smoking and nicotine - poison for Crohn's, potion for colitis?
  28 Heparin
  29 Leukocytapheresis: filtering out the facts
  30 Appendectomy for ulcerative colitis - a therapeutic option?
  31 Biologic treatments in IBD
  32 Stem cell transplantation for IBD
  33 Complementary and alternative therapy - the way forward or a step back?
• Part 4 Common Clinical Challenges: Beyond the Text Book
  34 Functional problems
  35 Psychological stress: something to worry about?
  36 Drugs to avoid
  37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?
  38 Iron replacement - is it safe and effective?
  39 Hepatitis B and C viruses - how do they affect management of IBD?
  40 Pregnancy: what drugs can we use?
  41 How to prevent growth failure in children
  42 Predicting outcomes in severe UC
  43 Refractory proctitis
  44 CMV co-infection - does it matter?
  45 Treatment of oral Crohn's disease
  46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease
  47 Short bowel
  48 Management of internal fistulae
  49 What is indeterminate colitis?
  50 Pouches for indeterminate colitis?
  51 Colitis-associated cancer: what's the risk to your patients?
  52 What to do with dysplasia, DALMs, and adenomas
• Part 5 Managing IBD Outside the Gut
  53 Pyoderma gangrenosum
  54 Arthritides - helping the joints without harming the gut
  55 Prevention and treatment of osteoporosis
  56 Sclerosing cholangitis - what to do?
  57 Thromboembolic disease: an under-recognized complication?
  58 Pulmonary manifestations: rare but real
• Part 6 Are You Sure it's IBD?
  59 Intestinal infections: mimics and precipitants of relapse
  60 Microscopic colitis
  61 Diverticular colitis
• Part 7 The IBD Service: Time for a Rethink?
  62 Outpatient services - do doctors still have a role?
  63 Shared care: tactical team selection
  64 Databases - are they worth the bother?
• Index

ABOUT THE AUTHOR

Peter Irving, Centre for Gastroenterology, Institute of Cell and Molecular Science, Barts and the London, Queen Mary School of Medicine and Dentistry, London, UK.

David Rampton, Professor of Clinical Gastroenterology at the Centre for Gastroenterology, Institute of Cell and Molecular Science, Barts and the London, Queen Mary School of Medicine and Dentistry, London, UK.

Fergus Shanahan, Professor and Chair of the Department of Medicine, National University of Ireland Cork, Cork University Hospital, Cork, Eire.